Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: August 29, 2022
Context: The filing announces the postponement of the Company's Annual General Meeting of Shareholders, originally scheduled for August 29, 2022.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a corporate governance notice regarding a meeting reschedule.
Material Changes
Meeting Reschedule: The Annual General Meeting has been reconvened to Monday, September 5, 2022, at 3:00 p.m. Israel time.
Location: The meeting will be held at the Company's offices at 10 Bareket Street, Petach Tikva, Israel.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, risk factors, or discussion of contingencies. It strictly addresses the logistical change to the shareholder meeting date.
Key Facts for Investors to Verify
- Confirm the new date and time for the Annual General Meeting (September 5, 2022, 3:00 p.m. Israel time).
- Verify the physical location of the meeting (10 Bareket Street, Petach Tikva, Israel).
- Check for subsequent filings regarding the agenda or outcomes of the rescheduled meeting.